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Bacterial speciation is a fundamental evolutionary process characterized by diverging 42 
genotypic and phenotypic properties. However, the selective forces impacting the genetic 43 
adaptations and how they relate to the biological changes that underpin the formation of a new 44 
bacterial species remain poorly understood. Here we reveal that the spore-forming, healthcare-45 
associated enteropathogen Clostridium difficile is actively undergoing speciation, and that 46 
diverging genetic lineages with distinct transmission properties formed prior to the advent of 47 
the modern healthcare system. Applying large-scale genomic analysis of 906 strains, we 48 
demonstrate that the ongoing speciation process is linked to positive selection on core genes in 49 
the newly forming species that are involved in spore formation and structure, and the 50 
metabolism of simple dietary sugars. Functional validation demonstrates the new C. difficile 51 
produce more resistant spores and show increased sporulation and host colonization capacity 52 
when glucose or fructose are available for metabolism. Thus, we reveal the formation of a new 53 
C. difficile species, selected for metabolizing simple dietary sugars and producing high levels 54 
of resistant spores, that is specialized for healthcare-mediated transmission. 55 
 56 
 57 
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The formation of a new bacterial species from its ancestor is characterised by genetic 66 
diversification and biological adaptation1-4. For decades, a polyphasic examination5, relying on 67 
genotypic and phenotypic properties of a bacterium, has been used to define and discriminate 68 
a “species”. The bacterial taxonomic classification framework has more recently used large 69 
scale genome analysis to incorporate aspects of a bacterium’s natural history, such as ecology6, 70 
horizontal gene transfer1, recombination2 and phylogeny3. Although a more accurate definition 71 
of a bacterial species can be achieved with whole genome-based approaches, we still lack a 72 
fundamental understanding of how selective forces impact adaptation of biological pathways 73 
and phenotypic changes leading to bacterial speciation. In this work, we describe a unique 74 
example of genome evolution and biological changes during the ongoing formation of a new 75 
C. difficile species that is highly specialised for human transmission in the modern healthcare 76 
system. 77 
C. difficile is a strictly anaerobic, Gram-positive bacterial species that produces highly 78 
resistant, metabolically dormant spores capable of rapid transmission between mammalian 79 
hosts through environmental reservoirs7. Over the past four decades, C. difficile has emerged 80 
as the leading cause of antibiotic-associated diarrhoea worldwide, with a large burden on the 81 
healthcare system7,8. To define the evolutionary history and genetic changes underpinning the 82 
emergence of C. difficile as a healthcare pathogen, we performed whole genome sequence 83 
analysis of 906 strains isolated from humans (n=761), animals (n=116) and environmental 84 
sources (n=29) with representatives from 33 countries and the largest proportion originating 85 
from the UK (n=465) (Supplementary Fig. 1; Supplementary Table 1; Supplementary Table 86 
2). This data is summarized visually here https://microreact.org/project/H1QidSp14. Our 87 
collection was designed to capture comprehensive C. difficile genetic diversity9 and includes 88 
13 high-quality and well-annotated reference genomes (Supplementary Table 2). Robust 89 
maximum likelihood phylogeny based on 1,322 concatenated single copy core genes (Fig. 1a; 90 
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Supplementary Table 3) illustrates the existence of four major phylogenetic groups within this 91 
collection. Bayesian analysis of population structure (BAPS) using concatenated alignment of 92 
1,322 single copy core genes corroborated the presence of the four distinct phylogenetic 93 
groupings (PGs 1-4) (Fig. 1a) that each harbour strains from different geographical locations, 94 
hosts and environmental sources which indicates signals of sympatric speciation. Each 95 
phylogenetic group also harbours distinct clinically relevant ribotypes (RT): PG1 (RT001, 002, 96 
014); PG2 (RT027 and 244); PG3 (RT023 and 017); PG4 (RT078, 045 and 033).  97 
The phylogeny was rooted using closely related species (C. bartlettii, C. hiranonis, C. 98 
ghonii and C. sordellii) as outgroups (Fig. 1a). This analysis indicated that three phylogenetic 99 
groups (PG1, 2 and 3) of C. difficile descended from the most diverse phylogenetic group 100 
(PG4). This was also supported by the frequency of SNP differences in pairwise comparisons 101 
between strains of PG4 and each of the other PGs versus the level of pairwise SNP differences 102 
between comparisons of PGs 1, 2 and 3 to each other (Supplementary Fig. 2). Interestingly, 103 
bacteria from PG4 display distinct colony morphologies compared to bacteria from PG 1, 2 104 
and 3 when grown on nutrient agar plates (Supplementary Fig. 3), suggesting a link between 105 
C. difficile colony phenotype and genotype that distinguishes PG 1, 2 and 3 from PG4. 106 
Our previous genomic study using 30 C. difficile genomes indicated an ancient, 107 
genetically diverse species that likely emerged 1 to 85 million years ago10. Testing this estimate 108 
using our larger dataset indicated the species emerged approximately 13.5 million years (12.7 109 
- 14.3 million) ago. Using the same BEAST11 analysis on our substantially expanded collection, 110 
we estimate the most recent common ancestor (MRCA) of PG4 (using RT078 clade) arose 111 
approximately 385,000 (297,137 - 582,886) years ago. In contrast, the MRCA of the PG1, 2 112 
and 3 groups (using RT027 clade) arose approximately 76,000 (40,220 – 214,555) years ago. 113 
Bayesian skyline analysis reveals a population expansion of PG1, 2 and 3 groups (using RT027 114 
clade) around 1595 A.D., which occurred shortly before the emergence of the modern 115 
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healthcare system in the 18th century (Supplementary Fig. 4). Combined, these observations 116 
suggest that PG4 emerged prior to the other PGs and that the PG1, 2 and 3 population structure 117 
started to expand just prior to the implementation of the modern healthcare system12. We 118 
therefore refer to PG4 as the “old” C. difficile and the PG1, 2 and 3 groups are referred to as 119 
“new” C. difficile. 120 
 To investigate genomic relatedness, we next performed pairwise Average Nucleotide 121 
Identity (ANI) analysis (Fig. 1b). This analysis revealed high nucleotide identity (ANI > 95%) 122 
between PGs 1, 2 and 3 indicating that bacteria from these groups belong to the same species; 123 
however, ANI between PG4 and any other PG was either less than the species threshold (ANI 124 
> 95%) or on the borderline of the species threshold (94.04 - 96.25%) (Fig. 1b). To detect 125 
recombination events within and between old and new C. difficile, FastGEAR analysis13 was 126 
performed on whole genome sequences of 906 strains (Supplementary Fig. 5). While analysis 127 
identified increased recombination within new C. difficile lineages (PG1 - PG2: 1 - 102, PG1 128 
- PG3: 1 - 214, PG2 - PG3: 1 - 96) (Supplementary Fig. 5) a restricted number of recombination 129 
events between old and new C. difficile was observed (PG1 - PG4: 1 - 20, PG2 - PG4: 1 - 25, 130 
PG3 - PG4: 1 - 46). This analysis strongly indicates the presence of recombination barriers in 131 
the core genome that further distinguishes new C. difficile from old C. difficile and could 132 
encourage sympatric speciation.  133 
 Functional analysis of the accessory genomes also shows a clear separation between 134 
new and old C. difficile (Supplementary Fig. 6a). Cell motility (including flagella) and mobile 135 
element functions are the most enriched functions in the accessory genome of new C. difficile 136 
(Supplementary Fig. 6b; Supplementary Table 4), whereas the accessory genome of old C. 137 
difficile is dominated by the uncharacterized function and DNA replication and modification 138 
functions (Supplementary Fig. 6c; Supplementary Table 5).  We also observe a higher number 139 
of pseudogenes in new C. difficile compared to old C. difficile (Supplementary Fig. 7; 140 
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Supplementary Table 6-9). Comparative functional analysis of pseudogenes between old and 141 
new C. difficile indicates phage-related function (n=13/24) is the largest functional category in 142 
new C. difficile (Supplementary Table 10), whereas old C. difficile is dominated by 143 
uncharacterized function (n=68/90) and transposons (13/90) (Supplementary Table 11). These 144 
results indicate different selection pressures on the accessory genomes of new C. difficile from 145 
old C. difficile. 146 
In addition to reduced rates of recombination events, advantageous genetic variants in 147 
a population driven by positive selective pressures, termed positive selection, are also a marker 148 
of speciation6. We determined the Ka/Ks ratios and identified 172 core genes in new C. difficile 149 
and 93 core genes in old C. difficile that were positively selected (Ka/Ks >1) (Fig. 2a; 150 
Supplementary Table 12; Supplementary Table 13). Functional annotation and enrichment 151 
analysis identified positively selected genes involved in carbohydrate and amino acid 152 
metabolism, sugar phosphotransferase system (PTS) and spore coat architecture and spore 153 
assembly in new C. difficile (Fig. 2b). In contrast, the sulphur relay system was the only 154 
enriched functional category found among the positively selected genes from the old C. difficile 155 
lineage. Notably, 26% (45 in total) of the positively selected genes in new C. difficile produce 156 
proteins that are either directly involved in spore production, are present in the mature spore 157 
proteome14 or are regulated by Spo0A15 or its sporulation-specific sigma factors16 (Fig. 2c). In 158 
contrast, no positively selected genes are directly involved in spore production in old C. 159 
difficile; however, 22.5% (21 genes in total) are either present in the mature spore proteome or 160 
are regulated by Spo0A or its sporulation specific sigma factors (Supplementary Fig. 8). The 161 
lack of overlap between sporulation-associated positively selected genes in the two lineages 162 
suggests a divergence of spore-mediated transmission functions. In addition, these results 163 
suggest functions important for host-to-host transmission have evolved in new C. difficile. 164 
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We found 20 positively selected genes (Supplementary Table 12) in new C. difficile 165 
whose products are components of the mature spore14,15 and could contribute to environmental 166 
survival. As an example, sodA (superoxide dismutase A), a gene associated with spore coat 167 
assembly17, has three-point mutations which are present in all new C. difficile genomes but 168 
absent in old C. difficile genomes (Supplementary Fig. 9). Spores derived from diverse C. 169 
difficile clades have a wide variation in resistance to microbiocidal free radicals from gas 170 
plasma18. To investigate if the phenotypic resistance properties of spores from the new lineage 171 
have evolved, we exposed spores from new and old C. difficile lineages to hydrogen peroxide, 172 
a commonly used healthcare environmental disinfectant17.  Spores derived from new C. difficile 173 
were statistically significantly more resistant to 3% (P=0.0317) and 10% hydrogen peroxide 174 
(P=0.0317) when compared to spores from old C. difficile, although there was no difference in 175 
survival at 30% peroxide likely due to the overpowering bactericidal effect at this concentration 176 
(P= 0.1667) (Fig. 3a). 177 
 The master regulator of C. difficile sporulation, Spo0A, is under positive selection in 178 
new C. difficile only. Spo0A also controls other host colonization factors, such as flagella, and 179 
carbohydrate metabolism, potentially serving to mediate cellular processes to direct energy to 180 
spore production and host colonization to facilitate host-to-host transmission15. Interestingly, 181 
the new C. difficile genomes contain genes under positive selection that are involved in fructose 182 
metabolism (fruABC and fruK), glycolysis (pgk and pyk), sorbitol (CD630_24170) and ribulose 183 
metabolism (rep1), and conversion of pyruvate to lactate (ldh). To further explore the link 184 
between sporulation and carbohydrate metabolism in new C. difficile, we analysed positively 185 
selected genes using KEGG pathways19 and manual curation. Manual curation of key enriched 186 
pathways across the 172 positively selected core genes in new C. difficile identified a complete 187 
fructose-specific PTS pathway and identified four genes (30%, 4/13) involved in anaerobic 188 
glycolysis during glucose metabolism (Supplementary Fig. 10). Other genes associated with 189 
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enriched PTS pathways include genes used for the cellular uptake and metabolism of mannitol, 190 
cellobiose, glucitol/sorbitol, galactitol, mannose and ascorbate. Furthermore, comparative 191 
analysis of carbohydrate active enzymes (CAZymes)20 identified a clear separation of 192 
CAZymes between new C. difficile and old C. difficile (Supplementary Fig. 11). Combined, 193 
these observations suggest a divergence of functions between new and old C. difficile linked 194 
to metabolism of a broad range of simple dietary sugars used in modern Western society21. 195 
The simple sugars glucose and fructose are increasingly used in diets within Western 196 
societies21. Interestingly, trehalose, a disaccharide of glucose, used as a food additive has 197 
impacted the emergence of some human virulent C. difficile variants22. Based on our genomic 198 
analysis, we hypothesized that dietary glucose or fructose could differentially impact host 199 
colonization by spores from new or old C. difficile. We therefore supplemented the drinking 200 
water of mice with either glucose, fructose or ribose and challenged with new or old C. difficile 201 
strains. Ribose metabolic genes were not under positive selection so this sugar was included as 202 
a control. Mice challenged with new C. difficile spores exhibited statistically significant 203 
increased bacterial load when exposed to dietary glucose (P= 0.048) or fructose (P= 0.0045) 204 
compared to old C. difficile (Fig. 3b). No difference in bacterial load was observed between 205 
new and old C. difficile without supplemented sugars or when supplemented with ribose (P= 206 
0.2709) (Fig. 3b). 207 
The infectivity and transmission of C. difficile within healthcare settings is facilitated 208 
by environmental spore density23,24. To determine the impact of simple sugar availability on 209 
spore production rates we assessed the ability of the two lineages to form spores in basal 210 
defined medium (BDM) alone or supplemented with either glucose, fructose or ribose. While 211 
no difference was observed on the ribose control (P= 0.3095), new C. difficile strains exhibited 212 
statistically significant increased spore production on glucose (P= 0.0317) and fructose (P= 213 
0.0317) (Fig. 3c). These results provide experimental validation and, together with our genomic 214 
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predictions, suggest that enhanced host colonization and onward spore-mediated transmission 215 
with the consumption of simple dietary sugars is a feature of new C. difficile but not old C. 216 
difficile. 217 
The rapid recent emergence of C. difficile as a significant healthcare pathogen has 218 
mainly been attributed to the genomic acquisition of antibiotic resistance and carbohydrate 219 
metabolic functions on mobile elements via horizontal gene transfer22,25. Here we show that 220 
these recent genomic adaptations have occurred in established, distinct evolutionary lineages 221 
each with core genomes expressing unique, pre-existing transmission properties. We reveal the 222 
ongoing formation of a new species, which we refer to as new C. difficile, with biological and 223 
phenotypic properties consistent with a transmission cycle that was primed for human 224 
transmission in the modern healthcare system (Fig. 3d). Indeed, different transmission 225 
dynamics and host epidemiology have also been reported for new C. difficile (027 clade26 and 226 
017 clade27) endemic in healthcare systems in different parts of the world, and the 078 clade 227 
that likely enters the human population from livestock28-30. Further, broad epidemiological 228 
screens of C. difficile present in the healthcare system often highlight high abundances of new 229 
C. difficile lineages as they represent 68.5% (USA), 74% (Europe) and 100% (Mainland China) 230 
of the infecting strains7,8,31,32. Thus, we reveal a link between new C. difficile speciation, 231 
adapted biological pathways and epidemiological patterns. In summary, our study elucidates 232 
how bacterial speciation may prime lineages to emerge and transmit in a process accelerated 233 
by modern human diet, the acquisition of antibiotic resistance or healthcare regimes. 234 
 235 
 236 
 237 
 238 
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Materials and Methods: 239 
Collection of C. difficile strains 240 
Laboratories worldwide were asked to send a diverse representation of their C. difficile 241 
collections to the Wellcome Sanger Institute (WSI). After receiving all shipped samples the 242 
DNA extraction was performed batch-wise using the same protocol and reagents to minimize 243 
bias. Phenol-Chloroform was the preferred method for extraction since it provides high DNA 244 
yield and intact chromosomal DNA.  245 
The genomes of 382 strains designated as C. difficile, by PCR ribotyping were sequenced and 246 
combined with our previous collection of 506 C. difficile strains, 13 high quality C. difficile 247 
reference strains and 5 publicly available C. difficile RT 244 strains making a total of 906 248 
strains analyzed in this study. This genome collection includes strains from humans (n=761), 249 
animals (n=116) and the environment (n=29) that were collected from diverse geographic 250 
locations (UK; n= 465, Europe; n= 230, N-America; n= 111, Australia; n= 62, Asia; n= 38). 251 
Details of all strains are listed in Supplementary Table 1 and Supplementary Table 2, including 252 
the European Nucleotide Archive (ENA) sample accession numbers. Metadata of this C. 253 
difficile collection has been made freely publicly available through Microreact33 254 
(https://microreact.org/project/H1QidSp14). The 13 C. difficile reference isolates 255 
(Supplementary Table 2) are publicly available from the National Collection of Type Cultures 256 
(NCTC) and the annotation of these genomes are available from the Host-Microbiota 257 
Interactions Lab (HMIL; www.lawleylab.com), WSI.  258 
Bacterial culture and genomic DNA preparation 259 
C. difficile strains were cultured on blood agar plates for 48 hours, inoculated into 260 
brain–heart infusion broth supplemented with yeast extract and cysteine and grown overnight 261 
(16 hours) anaerobically at 37 °C. Cells were pelleted, washed with PBS, and genomic DNA 262 
preparation was performed using a phenol–chloroform extraction as previously described34. 263 
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All culturing of C. difficile took place in anaerobic conditions (10% CO2, 10% H2, 80% N2) 264 
in a Whitley DG250 workstation at 37 °C. All reagents and media were reduced for 24 hours 265 
in anaerobic conditions before use. 266 
DNA sequencing, assembly and annotation 267 
Paired-end multiplex libraries were prepared and sequenced using Illumina Hi-Seq 268 
platform with fragment size of 200-300 bp and a read length of 100 bp, as previously 269 
described35,36. An in-house pipeline developed at the WTSI (https://github.com/sanger-270 
pathogens/Bio-AutomatedAnnotation) was used for bacterial assembly and annotation. It 271 
consisted of de novo assembly for each sequenced genome using Velvet v1.2.1037, SSPACE 272 
v2.038 and GapFiller v1.139 followed by annotation using Prokka v1.5-140. For the 13 high-273 
quality reference genomes, strains Liv024, TL178, TL176, TL174, CD305 and Liv022 were 274 
sequenced using 454 and Illumina sequencing platforms, BI-9 and M68 were sequenced using 275 
454 and capillary sequencing technologies with the assembled data for these 8 strains been 276 
improved to an ‘Improved High Quality Draft’ genome standard41. Optical maps using the 277 
Argus Optical Mapping system were also generated for Liv024, TL178, TL176, TL174, CD305 278 
and Liv022. The remaining strains are all contiguous and were all sequenced using 454 and 279 
capillary sequencing technologies except for R20291 which also had Illumina data 280 
incorporated and 630 which was sequencing using capillary sequence data alone. 281 
Phylogenetic analysis, Pairwise SNP distances analysis and Average Nucleotide Identity 282 
analysis 283 
The phylogenetic analysis was conducted by extracting nucleotide sequence of 1,322 284 
single copy core gene from each C. difficile genome using Roary42. The nucleotide sequences 285 
were concatenated and aligned with MAFFT v7.2043. Gubbins44 was used to mask 286 
recombination from concatenated alignment of these core genes and a maximum-likelihood 287 
tree was constructed using RAxML v8.2.845 with the best-fit model of nucleotide substitution 288 
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(GTRGAMMA) calculated from ModelTest embedded in TOPALi v2.546 and 500 bootstrap 289 
replicates. The phylogeny was rooted using a distance-based tree generated using Mash v2.047, 290 
R package APE48 and genome assemblies of closely related species (C. bartlettii, C. hiranonis, 291 
C. ghonii and C. sordellii). All phylogenetic trees were visualized in iTOL49. Genomes of 292 
closely related C. difficile were downloaded from NCBI. Pairwise SNP distances analysis was 293 
performed on concatenated alignment of 1,322 single copy core genes using SNP-Dist 294 
(https://github.com/tseemann/snp-dists). Average nucleotide analysis (ANI) was calculated by 295 
performing pairwise comparison of genome assemblies using MUMmer50. 296 
Population structure and recombination analysis 297 
Population structure based on concatenated alignment of 1,322 single copy core genes 298 
of C. difficile was inferred using the HierBAPS51 with one clustering layers and 5, 10 and 20 299 
expected numbers of clusters (k) as input parameters. Recombination events across the whole 300 
genome sequences were detected by mapping genomes against a reference genome (NCTC 301 
13366; RT027) and using FastGear13 with default parameters. 302 
Functional genomic analysis  303 
To explore accessory genome and identify protein domains in a genome, we performed 304 
RPS-BLAST using COG database (accessed February 2019)52. All protein domains were 305 
classified in different functional categories using the COG database52 and were used to perform 306 
Discriminant Analysis of Principle Components (DAPC)53 implemented in the R package 307 
Adegenet v2.0.154. Domain and functional enrichment analysis was calculated using one-sided 308 
Fisher’s exact test with p-value adjusted by Hochberg method in R v3.2.2.   309 
Carbohydrate active enzymes (CAZymes) in a genome were identified using dbCAN 310 
v5.055 (HMM database of carbohydrate active enzyme annotation). Best hits include hits with 311 
E-value < 1e-5 if alignment > 80 aa and hits with E-value < 1e-3 if alignment < 80 aa, and 312 
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alignment coverage > 0.3. Best hits were used to perform Discriminant Analysis of Principle 313 
Components (DAPC)53 implemented in the R package Adegenet v2.0.154.  314 
Functional annotation of positively selected genes was carried out using the Riley 315 
classification system56, KEGG Orthology57 and Pfam functional families58.  316 
Analysis of selective pressures.  317 
The aligned nucleotide sequences of each 1,322 single copy core genes were extracted 318 
from Roary's output. The ratio between the number of non-synonymous mutations (Ka) and 319 
the number of synonymous mutations (Ks) was calculated for the whole alignment and for the 320 
respective subsets of strains belonging to the PG1, 2, 3 as a group and PG4. The Ka/Ks ratio 321 
for each gene alignment was calculated with SeqinR v3.1. A Ka/Ks > 1 was considered as the 322 
threshold for identifying genes under positive selection.  323 
Pseudogenes analysis  324 
 Nucleotide annotations of genes within a genome within each phylogenetic group were 325 
mapped against the protein sequences of the reference genome for its phylogenetic group (PG1: 326 
NCTC 13307(RT012), PG2: SRR2751302 (RT244), PG3: NCTC 14169 (RT017), PG4: NCTC 327 
14173 (RT078)) using TBLASTN as previously described59. Pseudogenes were called based 328 
on following criteria: genes with E value > 1-30 and sequence identity < 99% and which are 329 
absent in 90% members of a phylogenetics group. Genes in the reference genomes annotated 330 
as a pseudogene were also included in addition to genes in query genomes. 331 
Analysis of estimating dates 332 
The aligned nucleotide sequences of each 222 core genes of C. difficile which are under 333 
neutral selection (Ka/Ks = 1) were extracted from Roary’s output. Gubbins44 was used to mask 334 
recombination from concatenated alignment of these core genes and used as an input for 335 
Bayesian Evolutionary Analysis Sampling Trees (BEAST) software package v2.4.111. In 336 
BEAST, the MCMC chain was run for 50 million generations, sampling every 1000 states 337 
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using the strict clock model (2.50 × 10−9 - 1.50 × 10−8 per site per year)10 and HKY four discrete 338 
gamma substitution model, each run in triplicate. Convergence of parameters were verified 339 
with Tracer v1.560 by inspecting the Effective Sample Sizes (ESS > 200). LogCombiner was 340 
used to remove 10% of the MCMC steps discarded as burn-ins and combine triplicates. The 341 
resulting file was used to infer the time of divergence from the most recent common ancestor 342 
for C. difficile, old and new C. difficile. The Bayesian skyline plot was generated with Tracer 343 
v1.560.  344 
C. difficile growth in vitro on selected carbon sources 345 
Basal defined medium (BDM)61 was used as the minimal medium to which selected 346 
carbon sources (2 g/L of glucose, fructose or ribose from Sigma-Aldrich) were added. C. 347 
difficile strains were grown on CCEY agar (Bioconnections) for two days; 125-ml Erlenmeyer 348 
flasks containing 10 mL of BDM with or without carbon sources were inoculated with C. 349 
difficile strains and incubated in anaerobic conditions at 37º C shaking at 180 rpm. After 48 350 
hours, spores were enumerated by centrifuging the culture to a pellet, carefully decanting the 351 
BDM and re-suspending in 70% ethanol for 4 hours to kill vegetative cells. Following ethanol 352 
shock, spores were washed twice in PBS and plated in a serial dilution on YCFA media 353 
supplemented with 0.1% sodium taurocholate. Colony forming units (representing germinated 354 
spores) were counted 24 hours later. Experiment was performed using 3 biological replicates 355 
for each strain. New strains used were TL178 (RT002/ PG1), TL174 (RT015/ PG1), R20291 356 
(RT027/ PG2), CF5 (RT017/ PG3) and CD305 (RT023/ PG3). Old strains used were MON024 357 
(RT033), CDM120 (RT078), WA12 (RT291), WA13 (RT228) and MON013 (RT127), all 358 
PG4. Data was presented using GraphPad Prism v7.03. 359 
C. difficile spore resistance to disinfectant 360 
Spores were prepared by adapting the previous protocol18. In brief, C. difficile strains 361 
were streaked on CCEY media, the cells were harvested from the plates 48 hours later and 362 
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subjecting to exposure in 70% ethanol for 4 hours to kill vegetative cells. The solution was 363 
then centrifuged, ethanol was decanted and the spores were washed once in 5ml sterile saline 364 
(0.9% w/v) solution before being suspended in 5ml of saline (0.9% w/v) with Tween20 (0.05% 365 
v/v). 300ul spore suspensions (at a concentration of approximately 106 spores) were exposed 366 
to 300ul of 3%, 10% and 30% hydrogen peroxide (Fisher Scientific UK Limited) solutions for 367 
5 minutes in addition to 300ul PBS. The suspensions were then centrifuged, hydrogen peroxide 368 
or PBS was decanted and the spores were washed twice with PBS. Washed spores were plated 369 
on YCFA media with 0.1% sodium taurocholate to stimulate spore germination and colony 370 
forming units were counted 24 hours later. Experiment was performed using 3 biological 371 
replicates for each strain. New strains used were TL178 (RT002/ PG1), TL174 (RT015/ PG1), 372 
R20291 (RT027/ PG2), CF5 (RT017/ PG3) and CD305 (RT023/ PG3). Old strains used were 373 
MON024 (RT033), CDM120 (RT078), WA12 (RT291), WA13 (RT228) and MON013 374 
(RT127), all PG4. Data was presented using GraphPad Prism v7.03. 375 
In vivo C. difficile colonisation experiment 376 
Five female 8-week-old C57BL/6 mice were given 250 mg/L clindamycin (Apollo 377 
Scientific) in drinking water. After 5 days, clindamycin treatment was interrupted and 100 mM 378 
of glucose, fructose or ribose was added to mouse drinking water for the rest of the experiment; 379 
no sugars were given to control mice. After 3 days, mice were infected orally with 6 x 103 380 
spore/mouse of C. difficile R20291 (RT027) or M120 (RT078) strain. Faecal samples were 381 
collected from all mice before infection to check for pre-existing C. difficile contamination. 382 
Spore suspensions were prepared as described above18. After 16 hours, faecal samples were 383 
collected from all mice to determine viable C. difficile cell counts by serial dilution and plating 384 
on CCEY agar supplemented with 0.1% sodium taurocholate. Data was presented using 385 
GraphPad Prism version 7.03. Mouse experiments were approved by the Wellcome Sanger 386 
Institute.  387 
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Figures: 554 
 555 
 556 
Figure 1. Phylogeny and population structure of Clostridium difficile. (A) Maximum 557 
likelihood tree of 906 C. difficile isolates constructed from the core genome alignment, 558 
excluding recombination events. Collapsed clades as triangles represent four Phylogenetic 559 
groups (PG1-4) identified by Bayesian analysis of population structure (BAPS). Number in 560 
parentheses indicate number of isolates. Key PCR ribotypes in each PG are shown. Bootstrap 561 
values of key branches are shown next to the branches. Clostridium bartlettii, Clostridium 562 
hiranonis, Clostridium ghonii and Clostridium sordellii were used as outgroups to root the tree. 563 
Scale bar indicates number of substitutions per site. (B) Distribution pattern of average 564 
nucleotide identity (ANI) for 906 C. difficile isolates. Pairwise ANI calculations between 565 
different PGs are shown in dark grey (PG1 and PG2), orange (PG1 and PG3), light blue (PG1 566 
and PG4), light green (PG2 and PG3), light yellow (PG2 and PG4), cyan (PG3 and PG4). 567 
Pairwise ANI calculations between strains of same PG are shown in dark orange (PG1), light 568 
pink (PG2), light red (PG3) and light grey (PG4). Dotted red line indicates bacterial species 569 
cut-off.  570 
 571 
 572 
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 573 
Figure 2. Adaptation of sporulation and metabolic genes in new Clostridium difficile 574 
lineage. Positive selection analysis of new and old C. difficile based on 1,322 core genes. (A) 575 
Distribution of Ka/Ks ratio for the positively selected genes in new C. difficile (n=172 genes) 576 
and old C. difficile (n=93 genes) is shown. Error bars are SEM. (B) Enriched functions in the 577 
positively selected genes of new (blue) and old (green) C. difficile are shown. Y–axis represent 578 
number of positive selected genes in each enriched function. All are statistically significant 579 
(sugar phosphotransferase system (q value < 1.7 x 10-3), fructose and mannose metabolism (q 580 
value < 1.18 x 10-3), sporulation, differentiation and germination (q value < 1.66 x 10-2), 581 
cysteine and methionine metabolism (q value < 2.80 x 10-3), sulphur relay system (q value < 582 
8.00 x 10-3)). (C) Positively selected sporulation-associated genes in new C. difficile are shown 583 
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in blue. Of the 172 genes under positive selection, 26% (45 in total) are either involved in spore 584 
production (sporulation stages I, III, IV and V), their proteins are present in the mature spore 585 
proteome or they are regulated by Spo0A or its sporulation specific sigma factors.  586 
 587 
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609 
Figure 3. Bacterial speciation is linked with increased host adaptation and transmission 610 
ability. (A) Spores of new C. difficile are more resistant to widely used hydrogen peroxide 611 
disinfectant. Spores of new and old C. difficile (n=5 different ribotypes for both lineages) were 612 
exposed to hydrogen peroxide for 5 minutes, washed and plated. Recovered CFUs representing 613 
surviving germinated spores were counted and presented as a percentage of spores exposed to 614 
PBS. Mean and range, Mann-Whitney unpaired two-tailed test (* P < 0.05). (B) Intestinal 615 
colonisation of new strains is increased in the presence of simple sugars compared to old 616 
strains. Comparison of vegetative cell loads between new (n=1, RT027) and old (n=1, RT078) 617 
C. difficile strains in mice whose diet was supplemented with different sugars. CFUs from 618 
faecal samples cultured 16 hours after C. difficile challenge are presented. Mean values of 5 619 
mice are shown, SEM, unpaired two-tailed t-test (* P < 0.05, **P < 0.005). (C) New strains 620 
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produce more spores in the presence of simple sugars. C. difficile new and old (n=5 different 621 
ribotypes for both lineages) strains were grown on basal defined media in the presence or 622 
absence of different sugars, vegetative cells were killed by ethanol exposure and the number 623 
of CFUs representing germinated spores were counted. The percentage of spores recovered in 624 
the presence of sugars compared to BDM alone is presented. Mean and range, Mann-Whitney 625 
unpaired two-tailed test (*P < 0.05). (D) Overview of adaptations in key aspects of the new C. 626 
difficile transmission cycle in human population. 627 
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Supplementary Figures: 646 
 647 
 648 
Supplementary Figure 1. Breakdown of 906 Clostridium difficile isolates based on 649 
metadata. A. Number of strains based on geographical location is shown in bar-plots. B. 650 
Number of strains based on source.  651 
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 665 
 666 
Supplementary Figure 2. Pairwise SNPs difference between different phylogenetic 667 
groups of Clostridium difficile. Boxplots show distribution of SNPs differences calculated 668 
between pairs of genomes belonging to different PGs.  669 
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 670 
Supplementary Figure 3. Colony morphology of Clostridium difficile strains. C. difficile 671 
strains from distinct clades were plated on YCFA agar plates supplemented with 0.1% sodium 672 
taurocholate and incubated for 8 days and C. difficile colonies were photographed. Ribotype 673 
(RT) 002, RT027, and RT017 represent PG1, 2 and 3 respectively. RT045, RT078 and RT033 674 
represent PG4. 675 
 676 
 28 
 677 
Supplementary Figure 4. Bayesian skyline plot of old (PG4; RT078) and new (PG2; RT027) Clostridium difficile indicate signals of new C. 678 
difficile expansion in the year 1595. The black line represents median estimate, and purple area represents its 95% highest posterior density 679 
intervals.  680 
 681 
 682 
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 683 
 684 
Supplementary Figure 5. Recombination analysis based on whole genome of 906 Clostridium 685 
difficile isolates. Phylogenetic groups of C. difficile are shown in circles. Direction of edges 686 
represent direction of recombination event (donor to recipient). Range of recombination events 687 
are shown on the edges. PG4 represents old C. difficile and group of PG1, 2 and 3 represent 688 
new C. difficile. 689 
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 691 
Supplementary Figure 6. Comparison of accessory genome between 4 phylogenetic 692 
groups (PGs) of Clostridium difficile. (A) Discriminant analysis of principal components 693 
using Clusters of Orthologous Groups (COGs) and accessory genome of strains from PG1 694 
(blue), PG2 (red), PG3 (purple), and PG4 (green). (B) Functional classification and distribution 695 
of enriched genes in the group of PG1, 2 and 3 as compared to PG4. (C) Functional 696 
classification and distribution of enriched genes in PG4 as compared to the group of PG1, 2 697 
and 3. PG4 represents old C. difficile and group of PG1, 2 and 3 represent new C. difficile. 698 
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706 
Supplementary Figure 7. High number of pseudogenes in new Clostridium difficile 707 
lineage. The bar-plot shows the number of pseudogenes in each phylogenetic groups (PGs): 708 
PG1 (blue), PG2 (red), PG3 (purple), and PG4 (green). of Clostridium difficile. PG4 represents 709 
old C. difficile and group of PG1, 2 and 3 represent new C. difficile. 710 
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 712 
Supplementary Figure 8. Sporulation-associated genes in old Clostridium difficile lineage. 713 
There are 21 sporulation-associated positively selected genes in PG4. These are all either 714 
present in the mature spore proteome or they are regulated by Spo0A or its sporulation specific 715 
sigma factors. There are no genes directly involved in producing a spore in any of the 716 
sporulation stages. PG4 represents old C. difficile. 717 
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 718 
Supplementary Figure 9. Multiple sequence alignment of the sodA gene from new and old 719 
Clostridium difficile. A nucleotide consensus sequence for 4 phylogenetic groups (PG1-4) is 720 
shown. Three-point mutations which are present in all new C. difficile genomes and absent in 721 
old C. difficile genomes are shown in black boxes. The amino-acids related to these mutations 722 
are mentioned. PG4 represents old C. difficile and group of PG1, 2 and 3 represent new C. 723 
difficile. 724 
     1
PG1  ATGAAGAAGAAGATCCTGATCCCCGTGATCATGAGCCTGTTCATCATCAG CCAGTGCATCACCAGCTTCGCCTTCACCCCCGAGAACAACAAGTTCAAGG
PG2  ATGAAGAAGAAGATCCTGATCCCCGTGATCATGAGCCTGTTCATCATCAG CCAGTGCATCACCAGCTTCGCCTTCACCCCCGAGAACAACAAGTTCAAGG
PG3  ATGAAGAAGAAGATCCTGATCCCCGTGATCATGAGCCTGTTCATCATCAG CCAGTGCATCACCAGCTTCGCCTTCACCCCCGAGAACAACAAGTTCAAGG
PG4  ATGAAGAAGAAGATCCTGATCCCCGTGATCATGAGCCTGTTCATCATCAG CCAGTGCATCACCAGCTTCGCCTTCACCCCCGAGAACAACAAGTTCAAGG
   101
PG1  TGAAGCCCCTGCCCTACGCCTACGACGCCCTGGAGCCCTACATCGACAAG GAGACCATGAAGCTGCACCACGACAAGCACTACCAGGCCTACGTGGACAA
PG2  TGAAGCCCCTGCCCTACGCCTACGACGCCCTGGAGCCCTACATCGACAAG GAGACCATGAAGCTGCACCACGACAAGCACTACCAGGCCTACGTGGACAA
PG3  TGAAGCCCCTGCCCTACGCCTACGACGCCCTGGAGCCCTACATCGACAAG GAGACCATGAAGCTGCACCACGACAAGCACTACCAGGCCTACGTGGACAA
PG4  TGAAGCCCCTGCCCTACGCCTACGACGCCCTGGAGCCCTACATCGACAAG GAGACCATGAAGCTGCACCACGACAAGCACTACCAGGCCTACGTGGACAA
   201
PG1  GCTGAACGCCGCCCTGGAGAAGTACCCCGAGCTGTACAACTACAGCCTGT GCGAGCTGCTGCAGAACCTGGACAGCCTGCCCAAGGACATCGCCACCACC
PG2  GCTGAACGCCGCCCTGGAGAAGTACCCCGAGCTGTACAACTACAGCCTGT GCGAGCTGCTGCAGAACCTGGACAGCCTGCCCAAGGACATCGCCACCACC
PG3  GCTGAACGCCGCCCTGGAGAAGTACCCCGAGCTGTACAACTACAGCCTGT GCGAGCTGCTGCAGAACCTGGACAGCCTGCCCAAGGACATCGCCACCACC
PG4  GCTGAACGTGGCCCTGGAGAAGTACCCCGAGCTGTACAACTACAGCCTGT GCGAGCTGCTGCAGAACCTGGACAGCCTGCCCAAGGACATCGCCACCGCC
   301
PG1  GTGAGGAACAACGCCGGCGGCGCCTACAACCACAAGTTCTTCTTCGACAT CATGACCCCCGAGAAGACCATCCCCAGCGAGAGCCTGAAGGAGGCCATCG
PG2  GTGAGGAACAACGCCGGCGGCGCCTACAACCACAAGTTCTTCTTCGACAT CATGACCCCCGAGAAGACCATCCCCAGCGAGAGCCTGAAGGAGGCCATCG
PG3  GTGAGGAACAACGCCGGCGGCGCCTACAACCACAAGTTCTTCTTCGACAT CATGACCCCCGAGAAGACCATCCCCAGCGAGAGCCTGAAGGAGGCCATCG
PG4  GTGAGGAACAACGCCGGCGGCGCCTACAACCACAAGTTCTTCTTCGACAT CATGACCCCCGAGAAGACCATCCCCAGCGAGAGCCTGAAGGAGGCCATCG
   401
PG1  ACAGGGACTTCGGCAGCTTCGAGAAGTTCAAGCAGGAGTTCCAGAAGAGC GCCCTGGACGTGTTCGGCAGCGGCTGGGCCTGGCTGGTGGCCACCAAGGA
PG2  ACAGGGACTTCGGCAGCTTCGAGAAGTTCAAGCAGGAGTTCCAGAAGAGC GCCCTGGACGTGTTCGGCAGCGGCTGGGCCTGGCTGGTGGCCACCAAGGA
PG3  ACAGGGACTTCGGCAGCTTCGAGAAGTTCAAGCAGGAGTTCCAGAAGAGC GCCCTGGACGTGTTCGGCAGCGGCTGGGCCTGGCTGGTGGCCACCAAGGA
PG4  ACAGGGACTTCGGCAGCTTCGAGAAGTTCAAGCAGGAGTTCCAGAAGGCC GCCCTGGACGTGTTCGGCAGCGGCTGGGCCTGGCTGGTGGCCACCAAGGA
   501
PG1  CGGCAAGCTGAGCATCATGACCACCCCCAACCAGGACAGCCCCGTGAGCA AGAACCTGACCCCCATCATCGGCCTGGACGTGTGGGAGCACGCCTACTAC
PG2  CGGCAAGCTGAGCATCATGACCACCCCCAACCAGGACAGCCCCGTGAGCA AGAACCTGACCCCCATCATCGGCCTGGACGTGTGGGAGCACGCCTACTAC
PG3  CGGCAAGCTGAGCATCATGACCACCCCCAACCAGGACAGCCCCGTGAGCA AGAACCTGACCCCCATCATCGGCCTGGACGTGTGGGAGCACGCCTACTAC
PG4  CGGCAAGCTGAGCATCATGACCACCCCCAACCAGGACAGCCCCGTGAGCA AGAACCTGACCCCCATCATCGGCCTGGACGTGTGGGAGCACGCCTACTAC
   601
PG1  CTGAAGTACCAGAACAGGAGGAACGAGTACATCGACAACTGGTTCAACGT GGTGAACTGGAACGGCGCCCTGGAGAACTACAAGAACCTGAAGAGCCAGG
PG2  CTGAAGTACCAGAACAGGAGGAACGAGTACATCGACAACTGGTTCAACGT GGTGAACTGGAACGGCGCCCTGGAGAACTACAAGAACCTGAAGAGCCAGG
PG3  CTGAAGTACCAGAACAGGAGGAACGAGTACATCGACAACTGGTTCAACGT GGTGAACTGGAACGGCGCCCTGGAGAACTACAAGAACCTGAAGAGCCAGG
PG4  CTGAAGTACCAGAACAGGAGGAACGAGTACATCGACAACTGGTTCAACGC CGTGAACTGGAACGGCGCCCTGGAGAACTACAAGAACCTGAAGAGCCAGG
   701
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Supplementary Figure 10. Positively selected genes of new C. difficile are shown in blue in 726 
the pathway of glucose and fructose in C. difficile. 727 
 728 
 729 
 730 
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Supplementary Figure 11. Functional diversity of carbohydrate-active enzyme in 4 732 
phylogenetic groups (PGs) of Clostridium difficile. Discriminant analysis of principal 733 
components using carbohydrate active enzymes (CAZymes) database. Each colour represents 734 
a strain from 4 PGs: blue (PG1); red (PG2); purple (PG3); and green (PG4). PG4 represents 735 
old C. difficile and group of PG1, 2 and 3 represent new C. difficile. 736 
